Home/Filings/4/0000950170-25-034006
4//SEC Filing

Kelly John Alexander 4

Accession 0000950170-25-034006

CIK 0001357874other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 7:00 PM ET

Size

7.2 KB

Accession

0000950170-25-034006

Insider Transaction Report

Form 4
Period: 2025-03-03
Kelly John Alexander
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-03-03+1,70286,256 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-031,7020 total
    Common Stock (1,702 underlying)
Footnotes (3)
  • [F1]Represents the vesting of Restricted Stock Units ("RSUs") on March 3, 2025.
  • [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]On March 3, 2022, the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on March 3, 2025.

Documents

1 file

Issuer

PRECISION BIOSCIENCES INC

CIK 0001357874

Entity typeother

Related Parties

1
  • filerCIK 0001590030

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 7:00 PM ET
Size
7.2 KB